Stocks are drifting in mixed trading on Wall Street Thursday after President Donald Trump’s latest tariffs took effect on ...

EXCLUSIVE: In the first of three roundtables featuring this year’s Emmy nominees for Outstanding Casting, Deadline gathered ...

Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo ...

Wednesday has made a comeback for its hotly anticipated second season, welcoming a whole host of new faces to the Addams ...

Eli Lilly shares plunged about 14% in midday trading Thursday after the company reported less-than-stellar results of a new study of an experimental anti-obesity pill that is expected to become a ...

US stocks were mixed Thursday as President Trump's sweeping tariffs hit dozens of US trade partners after his self-imposed ...

Eli Lilly’s experimental oral GLP-1 medication, orforglipron, led to an average weight loss of 12.4%, or 27.3 pounds, in a phase 3 trial involving more than 3,000 adults.  Based on the results, the ...

Mounjaro manufacturer Eli Lilly has unveiled the test results of its new oral GLP-1 medication, orforglipron. The obesity pill, which is designed to be taken daily by patients who are severely ...

Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight ...

How could higher U.S. tariffs on Indian pharmaceutical products impact drug stocks? Seeking Alpha analysts weigh in. Read ...

Despite Thursday’s choppy session, major indexes remain on track for weekly gains. The Nasdaq is up nearly 3% week to date, ...

Oasis fan Lee Claydon sadly died following a fall at the band's gig on Saturday night and now a photo shows him partying at ...